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0.56; 95%CI [0.33-0.95]). Subgroup analysis including only OSA showed a
similar result after adjustement (p=0.017; HR: 0.40; 95%CI [0.19-0.95]). In
multivariate cox analysis including all the polygraphic variables, only CSR
and minimal oxyhemoglobin saturation predicted adverse outcomes in all CHF
patients untreated for SDB but AHI.
Conclusion: In patients with CHF, ventilatory treatment of SDB is associ-
ated with a better outcome independently of confounding factors.
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Diagnostic performance of midregional proadrenomedullin in heart
failure: comparison with brain natriuretic peptide levels and the echo-
cardiographic assessment of left ventricular filling pressures
Delphine Baudouy [Orateur], Pamela Moceri
CHU Nice, Hôpital Pasteur, Cardiologie, Nice, France
Background: Acute decompensated heart failure is a challenging diagnosis
when natriuretic peptides are misleading. Midregional-proadrenomedullin
(MR-proADM) is a new prognostic peptide in heart failure.
Objectives: This preliminary study sought to assess the diagnostic accu-
racy of MR-proADM in heart failure in comparison with B-type natriuretic
peptide (BNP) according to the echocardiographic estimation of left ventric-
ular filling pressures (LVFP). The second purpose was to establish a cut-off
value of MR-proADM between stable and decompensated heart failure.
Methods: We measured BNP and MR-proADM plasma levels in 35 con-
secutive patients. Concomitantly, we performed a doppler echocardiography,
measuring the ratio of mitral velocity to early diastolic velocity of the mitral
annulus (E/e'). 25 patients were suspected of congestive heart failure and 10
patients were suffering from stable heart failure.
Results: Ischemic and dilated cardiomyopathies were the two major causes
of heart failure in our population (43% vs 31%), with only 17% of heart
failure with preserved ejection fraction. Median MR-proADM and BNP levels
were 0,94 nmol/L and 552 pg/mL respectively. Both plasma levels were
scaling up with the NYHA classification. The correlation between the E/e’
ratio and BNP levels was better than between E/e' and MR-proADM levels
(r=0,63 vs 0,41 respectively). A mild correlation was found between BNP and
MR-proADM, probably due to their shared prognostic value. MR-proADM
could classify most of the patients with intermediate BNP levels according to
the echocardiographic estimation of LVFP.
Conclusions: This preliminary study shows that MR-proADM may be of
interest for the diagnosis of decompensated heart failure in patients with inter-
mediate BNP levels. MR-proADM levels > 0,74 nmol/L would correlate with
the elevation of LVFP as determined by the E/e’ ratio, and thus be useful
when echocardiography is not available.
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Metaboreflex attenuation as a potential cause of improvement in the
ventilatory response after cardiac resynchronization therapy
Jérémie Jaussaud [Orateur], Laurie Aimable, Pierre Bordachar, Raymond
Roudaut, Hervé Douard
CHU Bordeaux, Bordeaux, France
Background: Patients suffering from heart failure (HF) have constant
exaggerated hyperventilation (high VE/VCO2) leading to breathlessness and
reduced exercise capacity. Metaboreflex over activation has been proposed to
partly explain this high ventilatory response during exercise.
Objective: We aim to investigate the modification of the metaboreflex
activation as a determinant in the improvement of the ventilatory response
6 months after CRT.
Methods and results: 10 HF patients (mean left ventricular ejection (LVEF)
27±4%, peak VO2 14±4 ml/kg/min, NYHA class 2,6±0,5; QRS duration
>120 ms) schedulded for CRT implantation were prospectively studied. At base-
line and after 6 month follow up two maximal cardiopulmonary exercise tests with
and without regional circulatory occlusion (RCO) were performed with contin-
uous VE, respiratory ratio (RR), VCO2 and VO2 measurements. RCO was
achieved by inflation of bilateral upper thigh tourniquets 30 mmHg above peak
systolic blood pressure during 3 minutes after peak exercise as previously
described. Metaboreflex contribution to the ventilatory response was assessed as
the difference in ventilatory data at the third minute during recovery between the
two tests (RCO – no RCO=). At baseline, patients had enhanced VE/VCO2
slope (40±9) and an evident metaboreflex contribution to the high ventilatory
response (VE: 3±4 L/min; p=0.01, RR: 4.5±4/min; p=0.01). 6 months after
CRT implantation, NYHA class, LVEF, peak VO2 and VE/VCO2 were signifi-
cantly improved (1,5±0,5; p<0.001, 42±7%; p<0.001, 16±4 ml/kg/min; p=0.005;
33±9; p=0.001). Metaboreflex contribution to ventilation was reduced compared
with baseline (VE: –1±5; p=0.08, RR: –1±3; p=0.01).
Conclusion: 6 months after CRT metaboreflex contribution to ventilation
is reduced and appears as an explanation in the ventilatory response improve-
ment in HF population.
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Tricuspid regurgitation changes after cardioverter-defibrillator implan-
tation: a prospective study
Colette Rio [Orateur], Pierre Nazeyrollas, Angeline Martin, Raphael San-
dras, François Lesaffre, Sophie Tassan-Mangina, Benoit Hercé, Jean
Pierre Chabert, Damien Metz
CHU Reims, Cardiologie, Reims Cedex, France
Introduction: it remains controversial whether pacemaker lead implanta-
tions could interfere with tricuspid valve function. The use of rigid and thicker
ventricular leads with implantable cardioverter-defibrillators (ICD) may
increase this risk. We realised a prospective study to analyse the tricuspid
valve function in this setting.
Method: we included patients needing a first ICD between october 2009
and may 2010 and performed echocardiographic recordings the day before
implantation, during the 3 following days and at 6 weeks. These records were
analysed offline independently by 2 cardiologists to assess and grade tricuspid
valve regurgitation (TR) using PISA and semi-quantitative method, and to
measure ventricular dimensions, function and pressures.
Results: we included 32 patients, 29 males, aged 61±14. Hypokinetic car-
diopathy accounted for 26 and 24 were implanted for primary prevention.
Ejection fraction was 35±14 %. Non significant TR was found in 23 patients
and only 2 patients has a tricuspid regurgitation greater than mild. The only
significant changes occurring immediately after defibrillator implantation con-
cerned TR, with a mean volume raising from 3.1±3.2 ml to 6.1±7.0 ml
(p<0.01) and a ROS from 0.03±0.3 to 0.06±0.07 cm² (p<0.01). Six TR
changed from not significant to minime (3) or mild (3), 3 from minime to
mild. Two patients with a baseline mild TR raised the regurgitant volume
from 11 ml to 19 ml and 30 ml. Mean regurgitant fraction increased from
5.5% to 10.5% and was higher in patients with a low ejection fraction and
mild TR at baseline. At 6 weeks, the results were similar. From a clinical
standpoint, no death occurred, and no worsening of heart failure was noticed.
Conclusion: we found a significant but minor increase in TR after defibril-
lator implantation, with no foreseeable consequences. However, our data hint
that this increase may be relevant in patients with the greater baseline regur-
gitation and the lower cardiac output
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Heart failure patterns in Djibouti (Horn of Africa): an epidemiologic
transition perspective
Pierre-Laurent Massoure [Orateur] (1), Eric Kaiser (1), Gatien Lamblin (1),
François Topin (1), Olivier Eve (1), Celine Dehan (1), Laurent Fourcade (2)
(1) Hôpital Bouffard, Djibouti, Djibouti – (2) Hôpital d’Instruction des
Armées Alphonse Laveran, Cardiologie, Marseille, France
Purpose: Cardiovascular disease patterns are changing in Africa. We
aimed to document the current heart failure (HF) patterns in Djibouti.
Methods: We prospectively included Djiboutian adults hospitalized for HF
in the French Military Hospital (Djibouti) between August 2008 and
December 2010. Clinical and prognosis data were recorded.
Results: Among 1688 adults hospitalized in the medicine department, 45
(2.7%) had symptomatic HF: 38 (84%) males, mean age 55.8 years (range 27-75).
Twenty five (56%) patients were initially hospitalized for acute pulmonary
oedema. New York Heart Association (NYHA) class was 2 (40%), 3 (44%) and
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4 (16%) one month after discharge from hospital. Underlying disease was coro-
nary artery disease (CAD) (62%) including previous myocardial infarction (83%
of patients with CAD), hypertensive heart disease (18%), rheumatic valvular dis-
ease (13%) and primitive dilated cardiomyopathy (7%). Cardiovascular risk fac-
tors were tobacco use (53%), hypertension (69%), diabetes (47%) and
hypercholesterolemia (51%). In the CAD group, patients were older and diabetes
was more frequent (p<0.01). Khat chewers (53%) were all males and smokers.
Severe renal failure was found in 20%. Mean left ventricular ejection fraction
(LVEF) was 39±14%. Atrial fibrillation was observed in 7%. During follow up
(14.4±9 months), 8 (18%) patients died, 9 (20%) had new hospitalization for HF
and 3 (7%) had an ischemic stroke. Higher NYHA classes were associated with
poorer outcomes (p= 0.03). Patients with LVEF 35% (n=24, 53%), were com-
pared with patients with LVEF >35% and no difference was observed in terms of
risk factors, underlying disease and outcome.
Conclusion: In hospitalized Djiboutian, most of HF patterns are similar to
those of industrialized countries. CAD is more prevalent than previously reported
in African patients with HF. Epidemiologic transition is a reality in Djibouti.
Urgent measures for the prevention of cardiovascular disease and HF are needed.
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Impact of sodium level on the prognosis of 1509 patients with chonic
heart failure
Hasnaa Salih [Orateur], Zineb Elhonsali, Roger Kongo, Ahmed Bennis
CHU Ibn Rochd, Casablanca, Maroc
Approximately 20% of heart failure patients have low levels of serum
sodium, often at a time when they are hospitalized during a period of decom-
pensation. It may reflect worsening heart failure and the deleterious effects of
activation of neurohormones. However, impact of hypernatremia, prognosti-
cally relevant cut-off values, and differential prognosis with reference range
serum sodium levels are not well defined.
Methods: Our aim was to prospectively assess the impact of baseline
natremia and changes in sodium level during median follow-up of 32 months
in 1509 patients. According to our central laboratory, hypo- and hyper-
natremia were defined as sodium levels <135 and >145 mmol/l. Chi2 test was
used, a difference was statistically considered significant if p<0.05.
Results: The prevalence of Hyponatremia was 12.45% and hypernatremia
was 0.9%. The mean age was 64.32 years (20-97), with a male predominance
(68.15%).There was a correlation between value of sodium levels and severity
of heart failure. The positive correlates of hyponatremia compared with nor-
monatremia were NYHA functional class [we find class III in 32.9% patients
vs 18.5% (p=0.0089) and class IV in 7.9% vs 2.09% (p=0.0075)], decompen-
sation found in 26.5% patients vs 12.04% (p=0.0085), renal dysfunction: mean
creatinine was at 15 vs 10mg per litre (p=0.0015), use of high dose of
diuretics 61.17% vs 40.46% (p=0.0012) and use of spironolactone 81,38% vs
51,50%(p=0.0082). Positive correlates of hypernatremia were intake of
diuretics 54.8% vs 40.46% (p=0.001), NYHA functional class [72.78% were
in class II vs 61.03% and 27.22% were in class III vs 18.5% (p=0.002 )], dec-
ompensation in 38.8% vs 12.04% (p=0;001)
Conclusion: The severity of heart failure, the renal function and medication
were associated with serum sodium levels. Our data indicate the need of further
research into optimized management of sodium-water homeostasis in heart failure.
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Incidence and predictors of worsening renal function in 1500 patients
with chronic heart failure
Hasnaa Salih [Orateur], Karim Benjelloun, Siham Jemali, Ahmed Bennis
CHU Ibn Rochd, Casablanca, Maroc
Introduction: Renal dysfunction (RD) is common in patients with chronic
heart failure (CHF) and predicts a worse outcome The aim of our study is to
determine the prevalence and incidence of renal dysfunction (RD) in patients
with chronic heart failure (CHF), to compare the clinical characteristics of
patients with different severities of RD and to identify contributory factors and
predictors of worsening renal function (WRF).
Material And Methods: This was a single centre, observational and
comparative study. We included 1500 patients followed for CHF with left
ventricular ejection fraction 45% in Ibn Rochd Center of Cardiology from
May 2006 to October 2010. The glomerular filtration rate (GFR) calculated by
the simplified modification of diet in renal disease (MDRD) was used to deter-
mine renal function . We divided patients in four groups based upon the base-
line GFR (normal 90 mL/min, mild impairment 60-89 mL/min, moderate
impairment 30-59 mL/min, and severe renal impairment 29 mL/min). WRF
was defined as an increase in serum creatinine of >26.5 mmol/L (>0.3 mg/dL).
Results: The mean age of our patients was 63±12.14 years (16-100), and
67% were men. Mean ejection fraction was 33%. GFR was normal (90 mL/min)
in only 150 patients (10%), mildly reduced (60-89 mL/min) in 525 patients
(35%), moderately reduced (30-59 ml/min) in 645 patients (43%), and mark-
edly reduced (29 ml/min) in 180 patients (12%). Patients with severely
impaired renal function were older, more often male and had lower left ven-
tricular ejection fractions, and haemoglobin levels than patients with normal
or mildly impaired renal function.
During 12 months, WRF occurred in 390 (26%) patients. Predictors of
WRF were renal dysfunction at baseline, diabetes, NYHA classes III-IV, and
systolic blood pressure > 140mmhg.
Conclusion: In patients with CHF, RD is common, commonly deteriorates
over a relatively short period of time and associated with poor prognosis.
Better knowledge of predictors of worsening renal function, allows selecting
groups at high risk where néphroprotective measures must be strengthened.
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Myocardial fibrosis and left ventricular non compaction in north afri-
can patients
Amal Lachhab [Orateur] (1), Nawal Doghmi (1), Youssef Elfakir (2),
Omar Taoussi (2), Aatef Benyass (3), Laila Haddour (1), Jamila Zarzur
(1), Rhizlane Cherradi (1), Ibtissam Fellat (1), Aicha Aouad (1), Fedoua
Ellouali (1), Ilyas Asfalou (3), Amin Elmajhad (1), Mohamed Cherti (1)
(1) CHU Ibn Sina, Cardiologie B, Rabat, Maroc – (2) Centre de Radiolo-
gie Nakhil, Rabat, Maroc – (3) HMIMV, Cardiologie, Rabat, Maroc
Background: Left ventricular non compaction (LVNC) is a recently rec-
ognized genetic cardiomyopathy. Many studies demonstrated areas of myocar-
dial fibrosis in patients with LVNC. However, there is still many uncertainties
related to the pattern of fibrosis especially in North African patients.
Methods: In our retrospective cohort, twelve patients (7 male, mean age 53+/
–8 years) underwent magnetic resonance imaging (cine and delayed enhancement
sequences) for suspected LVNC. The diagnosis of isolated LVNC was based on
Petersen criteria. For each patient, the distribution of non-compaction was assessed
by qualitative analysis of all seventeen left ventricular segments, according to stan-
dard seventeen-segment cardiac model. The presence or absence of late gado-
linium enhancement (LGE), a surrogate of fibrosis, was qualitatively determined
for each left ventricular myocardial segment.
Results: Non compaction was more commonly observed at the apex, the
anterior wall and the lateral wall, especially on their apical and mid-cavity
segments. A total of four (33%) patients showed LGE. All those patients had
impaired left ventricular ejection fraction. Myocardial fibrosis was mid-myo-
cardial in two cases and sub-endocardial in the remaining ones. Overall, LGE
was seen in twenty-two LV segments, thirteen (59%) of which were com-
pacted segments, while the others (41%) were non-compacted. No association
was found between the pattern of fibrosis and non compaction distribution
(OR=2,2, CI [0,91-5,55], p=0,076).
Conclusion: In North African population with LVNC, myocardial fibrosis is
observed in non compacted and compacted segments with a similar prevalence.
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Does the physical examination still have a role in patients with poten-
tial chronic heart failure?
Thibaud Damy [Orateur] (1), Anna Bennet (2), Kevin Goode (2), Jean-Luc
Dubois-Rande (1), Luc Hittinger (1), John Gf Cleland (2), Andrew Clark (2)
(1) AP-HP, CHU Henri Mondor, Fédération de Cardiologie, Créteil,
France – (2) NHS trust East Yorkshire, Academic Cardiology, Cottin-
gham, United Kingdom
Background: Prognostic value of signs of congestion in chronic heart
failure (CHF) is unknown.
